紫翔生物 (833866.OC)

+ 收藏

资产负债表(紫翔生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 7,030,812.527,552,550.9613,326,750.2513,518,160.366,017,652.85
  其中:交易性金融资产(元) 688,658.60816,517.90857,769.50797,633.90777,452.80
 应收票据及应收账款(元) 47,463,128.6748,993,502.8845,204,344.4945,160,808.4835,352,078.84
  其中:应收账款(元) 47,463,128.6748,993,502.8845,204,344.4945,160,808.4835,352,078.84
 预付款项(元) 3,976,820.29120,009.99197,005.601,628,622.782,298,444.08
 其他应收款(元) 5,286,218.566,135,063.606,513,041.607,600,829.744,443,261.28
 存货(元) 10,392,652.587,853,940.435,071,846.333,089,121.897,189,883.25
 合同资产(元) ----1,109,960.00
 其他流动资产(元) 3,089.5197,784.81146,296.99112,377.93174,552.23
 流动资产合计(元) 74,841,380.7371,569,370.5771,317,054.7671,907,555.0857,363,285.33
非流动资产:
 长期股权投资(元) 1,075,860.201,176,071.331,356,924.881,533,747.051,873,499.98
 其他权益工具投资(元) 999,259.26999,259.26999,259.26999,259.26999,339.20
 固定资产(元) 17,094,942.3517,832,157.1918,692,520.1419,212,516.3618,912,817.17
 在建工程(元) ----5,393,858.31
 长期待摊费用(元) 5,717,024.916,037,449.456,091,477.886,514,060.25-
 递延所得税资产(元) -279,441.35---
 非流动资产合计(元) 24,887,086.7226,324,378.5827,140,182.1628,259,582.9227,179,514.66
资产总计(元) 99,728,467.4597,893,749.1598,457,236.92100,167,138.0084,542,799.99
流动负债:
 短期借款(元) 174,600.00174,779.453,499,600.004,432,158.49926,000.00
 应付票据及应付账款(元) 10,196,553.637,001,436.034,956,868.469,494,329.644,005,960.05
  其中:应付票据(元) ---2,347,780.00-
  其中:应付账款(元) 10,196,553.637,001,436.034,956,868.467,146,549.644,005,960.05
 合同负债(元) 159,582.30128,940.51148,741.30993,978.27180,201.70
 应付职工薪酬(元) 1,569,330.502,199,871.071,663,813.132,165,324.522,475,937.16
 应交税费(元) 769,930.751,859,108.52753,367.051,642,462.76360,240.79
 其他应付款(元) 552,883.90551,585.40655,984.921,775,318.80855,009.51
 一年内到期的非流动负债(元) ---8,009,900.00-
 其他流动负债(元) -11,576.79-119,640.93-
 流动负债合计(元) 13,422,881.0811,927,297.7711,678,374.8628,633,113.418,803,349.21
非流动负债:
 长期借款(元) 7,480,000.007,498,353.437,500,000.00-8,000,000.00
 非流动负债合计(元) 7,480,000.007,498,353.437,500,000.00-8,000,000.00
负债合计(元) 20,902,881.0819,425,651.2019,178,374.8628,633,113.4116,803,349.21
所有者权益(或股东权益):
 实收资本或股本(元) 15,850,000.0015,850,000.0015,850,000.0015,850,000.0015,850,000.00
 资本公积(元) 3,767,221.973,767,221.973,767,221.973,767,221.973,767,221.97
 其他综合收益(元) -740.74-740.74-740.74-740.74-660.80
 盈余公积(元) 7,925,000.007,925,000.006,856,767.636,856,767.636,853,499.66
 未分配利润(元) 51,437,759.1750,792,549.3452,355,889.1644,481,229.5341,250,690.20
 归属于母公司股东权益合计(元) 78,979,240.4078,334,030.5778,829,138.0270,954,478.3967,720,751.03
 少数股东权益(元) -153,654.03134,067.38449,724.04579,546.2018,699.75
 股东权益合计(元) 78,825,586.3778,468,097.9579,278,862.0671,534,024.5967,739,450.78
负债和股东权益合计(元) 99,728,467.4597,893,749.1598,457,236.92100,167,138.0084,542,799.99
公告日期 2024-08-222024-04-262023-08-232023-03-072022-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院